Cytoimmunologic monitoring and heart transplantation.

Article

Cytoimmunologic monitoring and heart transplantation.

The Journal of heart transplantation - 1 Jan 2000

Hanson C A, Bolling S F, Stoolman L M, Schlegelmilch J A, Abrams G D, Miska P T, Deeb G M

Abstract excerpt

Cytoimmunologic monitoring (CIM) combines morphological quantitation of activated lymphocytes and immunoblasts with immunophenotyping of peripheral blood in an effort to identify patients at risk for heart transplant rejection. In this study, CIM and endomyocardial biopsy (EMB) results were corre...

Topics

Antibodies, Monoclonal
Biopsy
Graft Rejection
Heart Transplantation
Humans
Lymphocyte Activation
Monitoring, Immunologic
Myocardium
Phenotype
Risk Factors
T-Lymphocytes

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.